AI Explanation
A concise explanation of the article's key points.
The number I kept circling was 8.0x. That was the top end of the range for a four-clinic veterinary group in the Midlands with GBP 3.4M revenue and GBP 640K EBITDA. The owners came in expecting 6.0x because that is what they heard at conferences. The real story was that veterinary practice valuation multiples were moving, but only for practices that looked repeatable and not founder-dependent.
Here is the thing I tell every owner in this sector: PE is not buying your passion for animal care. They are buying durable cash flow and a platform they can scale. That is why veterinary practice valuation multiples can jump by 1.5 to 2.0 turns when you remove the right risks.
I have also watched owners miss the consolidation wave. One partner in 2022 insisted on a quick sale at 6.1x. Eighteen months later, the buyer flipped the same clinics into a PE platform at 7.6x. The assets did not change; the risk story did.
Why PE is pushing veterinary practice valuation multiples upward
Most brokers will tell you the market is hot, but that misses the point. PE pays up when a clinic group looks like a platform: recurring revenue, low customer churn, and a leadership team that can run without the founders. That combination turns veterinary practice valuation multiples from a rumor into a defensible range.
- 01Recurring plans that cover wellness and chronic care reduce volatility for PE underwriters.
- 02Multi-site operations create cost leverage and procurement savings buyers can model.
- 03A strong medical director bench lowers key-person risk, which is the fastest multiple killer.
The 14-month roadmap that moved the range
- 01
Month 0-1: baseline valuation and risk map
We ran a DCF and a multiples check and landed at 6.1x to 6.6x. The risk map highlighted owner production at 62% and inconsistent wellness plan uptake. - 02
Months 2-4: normalize EBITDA
We adjusted owner compensation and removed one-off equipment spend, moving EBITDA from GBP 590K to GBP 640K. That alone lifted the range by roughly 0.2x in veterinary practice valuation multiples. - 03
Months 5-7: build repeatability
We documented clinical protocols, standardized pricing, and added a second lead vet per site. The goal was to make the clinics run without the founders carrying every complex case. - 04
Months 8-10: recurring revenue push
We redesigned wellness plans and trained front-desk teams to enroll clients. Recurring revenue moved from 18% to 28% over two quarters. - 05
Months 11-12: data room build
We compiled 58 documents: three years of financials, payroll, clinical KPIs, lease terms, equipment logs, and customer cohorts. Diligence time fell because the answers were already there. - 06
Months 13-14: buyer process
We approached 14 PE and strategic buyers. Four LOIs arrived within six weeks, with the top bid at 8.0x and 82% cash at close.
The metrics that actually changed the multiple
Wellness plan revenue
Clinician retention
Owner production
Multi-site EBITDA margin
Why structure can beat the headline multiple
01
PE platform buyer
02
Strategic or regional buyer
The LOI mistake I made and how I fix it now
Key takeaways
- 01
Veterinary practice valuation multiples rise when cash flow looks repeatable without the founder.
- 02
PE buyers paid up for 28% wellness-plan revenue and stable clinician retention.
- 03
A 14-month preparation cycle moved this deal from 6.1x to 8.0x EBITDA.
- 04
I now treat structure as a valuation driver, not an afterthought.
- 05
Most advisors chase the headline multiple, but the cash-at-close number is what matters.
Replicable checklist
- 01Run a baseline valuation and document the risks that compress veterinary practice valuation multiples.
- 02Normalize EBITDA with defensible add-backs and keep a clean audit trail.
- 03Grow recurring wellness-plan revenue and track cohort retention monthly.
- 04Reduce owner production by building associate coverage and clinical leaders.
- 05Build a buyer-ready data room before you open conversations.
Conclusion
Veterinary practice valuation multiples are rising, but only for clinics that look like scalable platforms. PE does not pay for chaos. It pays for repeatable cash flow, stable teams, and a leadership bench that survives after you exit. If you want the 8.0x range, build the evidence early and run a process that creates competitive pressure.
If you want a baseline on your own veterinary practice valuation multiples before the first buyer call, start with a DCF and a clean EBITDA bridge. That gives you the map for the 12 to 18 months that actually move price.
Frequently asked questions
- What are typical veterinary practice valuation multiples today?
- In my recent deals I have seen 5.8x to 8.2x EBITDA depending on scale, clinician retention, and recurring revenue. The upper end usually requires multi-site operations and strong wellness-plan adoption.
- Do PE buyers always pay more than strategics?
- Not always. PE may headline a higher multiple, but structure can reduce cash at close. I compare total proceeds and risk, not just the multiple.
- How long does it take to improve veterinary practice valuation multiples?
- Expect 12 to 18 months. You can get a valuation in weeks, but the multiple moves when you fix retention, recurring revenue, and owner dependency.
Start your exit
Calculate your business value.
Professional DCF-based valuation in 10 minutes. See how your company compares.
Filed under
Written by
James Crawford
M&A Advisor & Former Investment Banker
James Crawford spent 10+ years in investment banking before transitioning to M&A advisory. He now helps SME owners understand their business value and prepare for successful exits. Based in London, he works with companies across Europe and brings a practical, no-nonsense approach to valuation and deal-making.
Keep reading
More from this category
- 01
I lost a client 2.4 million euros because of one spreadsheet mistake
The number €2,400,000 still haunts me. It was 2019, and I was lead advisor for a logistics firm in Munich—very similar to the Schmidt Logistics case I often cite.
- 02
Valuing a Healthcare Tech Business: 2026 M&A Multiples and Key Risk Factors
The healthcare technology sector continues to be a hotbed for M&A activity, driven by digital transformation, an aging population, and increasing demand for efficient patient care.
- 03
E-commerce valuation reset: how D2C brands are valued in the post-COVID market
The e-commerce landscape has undergone a significant 'valuation reset' in the post-COVID market.
Popular valuation guides
- 01
Business Valuation Methods: Complete Guide
A founder-friendly overview of income, market, and asset-based valuation approaches with guidance on when to blend methods.
- 02
DCF Valuation: Complete Guide
A practical, founder-friendly walkthrough of building, debating, and presenting a discounted cash flow model with defensible assumptions.
- 03
Adjusted EBITDA: Complete Calculation Guide
Learn how to calculate Adjusted EBITDA, document add-backs, and use the metric to benchmark valuation multiples with confidence.
Share this article